Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma (Q44303927)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma |
scientific article |
Statements
1 reference
Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma (English)
1 reference
Hamberg AP
1 reference
Korse CM
1 reference
Bonfrer JM
1 reference
de Gast GC
1 reference
1 February 2003
1 reference
1 reference
13
1 reference
1
1 reference
45-49
1 reference
Identifiers
1 reference
1 reference